A First in Human Experience with a Novel Spinosad-Based Therapeutic for Patients with Blepharitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to establish the clinical efficacy of APT-001 topical therapy 1.8% in patients with blepharitis as compared to its vehicle control, and to establish that the therapeutic is safe and generally well tolerated by patients.
Epistemonikos ID: b2d93788862ae6f9f9c46851076aa7bd38edc771
First added on: Jan 01, 2025